RXST
RxSight Inc

471
Mkt Cap
$538.22M
Volume
587,574.00
52W High
$39.37
52W Low
$6.32
PE Ratio
-14.37
RXST Fundamentals
Price
$12.62
Prev Close
$13.09
Open
$13.00
50D MA
$9.70
Beta
1.56
Avg. Volume
884,562.84
EPS (Annual)
-$0.7064
P/B
1.88
Rev/Employee
$280,977.91
Loading...
Loading...
News
all
press releases
Divisadero Street Capital Management LP Has $2.85 Million Stock Position in RxSight, Inc. $RXST
Divisadero Street Capital Management LP reduced its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 75.3% during the 2nd quarter, according to its most recent 13F filing with the Securities...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
RxSight, Inc. (NASDAQ:RXST) Given Average Rating of "Reduce" by Brokerages
Shares of RxSight, Inc. (NASDAQ:RXST - Get Free Report) have been assigned an average recommendation of "Reduce" from the thirteen research firms that are presently covering the stock, Marketbeat...
MarketBeat·6d ago
News Placeholder
AXQ Capital LP Invests $405,000 in RxSight, Inc. $RXST
AXQ Capital LP bought a new position in RxSight, Inc. (NASDAQ:RXST - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange...
MarketBeat·19d ago
News Placeholder
76,728 Shares in RxSight, Inc. $RXST Bought by Dynamic Technology Lab Private Ltd
Dynamic Technology Lab Private Ltd bought a new position in RxSight, Inc. (NASDAQ:RXST - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm...
MarketBeat·20d ago
News Placeholder
RxSight, Inc. (NASDAQ:RXST) Receives Consensus Recommendation of "Reduce" from Brokerages
RxSight, Inc. (NASDAQ:RXST - Get Free Report) has received a consensus recommendation of "Reduce" from the thirteen research firms that are covering the stock, MarketBeat reports. Three equities...
MarketBeat·1mo ago
News Placeholder
107,000 Shares in RxSight, Inc. $RXST Bought by Carnegie Lake Advisors LLC
Carnegie Lake Advisors LLC acquired a new stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·1mo ago
News Placeholder
JPMorgan Chase & Co. Issues Positive Forecast for RxSight (NASDAQ:RXST) Stock Price
JPMorgan Chase & Co. boosted their price target on RxSight from $8.00 to $9.00 and gave the stock an "underweight" rating in a research report on Thursday...
MarketBeat·1mo ago
News Placeholder
RxSight (NASDAQ:RXST) Price Target Raised to $10.00
Wells Fargo & Company increased their target price on RxSight from $9.00 to $10.00 and gave the company an "equal weight" rating in a report on Thursday...
MarketBeat·1mo ago
News Placeholder
Needham & Company LLC Issues Positive Forecast for RxSight (NASDAQ:RXST) Stock Price
Needham & Company LLC lifted their target price on shares of RxSight from $11.00 to $12.00 and gave the stock a "buy" rating in a report on Thursday...
MarketBeat·1mo ago
News Placeholder
RxSight (NASDAQ:RXST) Issues Earnings Results, Beats Expectations By $0.15 EPS
RxSight (NASDAQ:RXST - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of...
MarketBeat·1mo ago

Latest RXST News

View

Advertisement|Remove ads.

Advertisement|Remove ads.